Abstract:In response to infection or vaccination, a successful antibody response must enrich high-affinity antigen-reactive B-cells through positive selection, but eliminate auto-reactive B-cells through negative selection. B-cells receive signals from the B-cell receptor (BCR) which binds the antigen, and the CD40 receptor which is stimulated by neighboring T-cells that also recognize the antigen. How BCR and CD40 signaling are integrated quantitatively to jointly determine B-cell fate decision and proliferation remains unclear. To investigate this, we developed a differential-equations-based model of the BCR and CD40 signaling networks activating NFκB. Our model accurately recapitulates the NFκB dynamics of B-cells stimulated through their BCR and CD40 receptors, correctly predicting that costimulation induces more NFκB activity. However, when linking it to established cell fate decision models of cell survival and cell cycle control, it predicted potentiated population expansion that was not observed experimentally. We found that this discrepancy was due to a time-dependent functional antagonism exacerbated by BCR-induced caspase activity that can trigger apoptosis in founder cells, unless NFκB-induced survival gene expression protects B-cells in time. Guided by model predictions, sequential co-stimulation experiments revealed how the temporal dynamics of BCR and CD40 signaling control the fate decision between negative and positive selection of B-cell clonal expansion. Our quantitative findings highlight a complex non-monotonic integration of BCR and CD40 signals that is controlled by a balance between NFκB and cell-death pathways, and suggest a mechanism for regulating the stringency of B-cell selection during an antibody response.

What problem does this paper attempt to address?

The problem this paper attempts to address is: how to quantitatively understand the synergy and antagonism between B cell receptor (BCR) and CD40 receptor signaling in B cell proliferation and fate determination. Specifically, the researchers developed a mathematical model based on differential equations to simulate the activation of the NFκB pathway by BCR and CD40 signaling networks. Through this model, they aim to reveal how these two signals jointly determine B cell fate choices and proliferation, particularly the balance between positive and negative selection. ### Main Issues: 1. **Signal Integration Mechanism**: How BCR and CD40 signals interact in time and space to jointly determine B cell fate and proliferation. 2. **Synergy and Antagonism**: Whether there are synergistic or antagonistic effects between these two signals under different doses of BCR and CD40 stimulation, and the specific mechanisms of these effects. 3. **Cell Survival and Death**: How BCR-induced apoptosis affects overall B cell proliferation, especially under high-dose BCR stimulation. 4. **NFκB Signal Saturation**: Whether high-dose CD40 stimulation leads to NFκB signal saturation, thereby limiting the further contribution of BCR signaling. ### Research Background: - **Immune Response**: B cells need to undergo positive selection (enriching high-affinity antigen-reactive B cells) and negative selection (eliminating self-reactive B cells) during antibody generation. - **Signaling Pathways**: Both BCR and CD40 signaling pathways converge on the NFκB signaling system, but their modes of action and temporal dynamics differ. - **Existing Research**: Although there are many studies on BCR and CD40 signaling pathways, there is a lack of understanding of how these two signals are quantitatively integrated. ### Research Methods: - **Mathematical Modeling**: Developed a mathematical model that includes BCR and CD40 signaling networks and combined it with existing cell fate decision models. - **Experimental Validation**: Validated the model's predictions with experimental data, particularly B cell proliferation and NFκB activity under different doses of BCR and CD40 stimulation. ### Key Findings: - **Synergistic Effect**: Under low-dose BCR and CD40 stimulation, the two signals exhibit a synergistic effect, promoting B cell proliferation. - **Antagonistic Effect**: Under high-dose BCR and CD40 stimulation, BCR-induced apoptosis may counteract its pro-survival effect through the NFκB signaling pathway, leading to reduced overall proliferation. - **NFκB Signal Saturation**: High-dose CD40 stimulation may lead to NFκB signal saturation, preventing BCR signaling from further enhancing NFκB activity. ### Conclusion: This study, through mathematical modeling and experimental validation, reveals the complex interactions between BCR and CD40 signaling in B cell fate determination and proliferation, particularly the dose-dependent and temporal dynamics of synergy and antagonism. These findings contribute to a deeper understanding of the selection mechanisms of B cells in immune responses.

Synergy and antagonism in the integration of BCR and CD40 signals that control B-cell proliferation

A Model Integrating Tonic and Antigen-Triggered BCR Signals to Predict the Survival of Primary B Cells.

A Stochastic Model of the Germinal Center Integrating Local Antigen Competition, Individualistic T-B Interactions, and B Cell Receptor Signaling.

Opposing roles of IgM and IgD in BCR-induced B cell survival.

BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia

Coupled feedback regulation of nuclear factor of activated T-cells (NFAT) modulates activation-induced cell death of T cells

Elucidating synergistic and antagonistic effects of B cell receptor and toll-like receptors 3, 4, and 9 in B cell activation

Quantitative modeling of signaling in aggressive B cell lymphoma unveils conserved core network

Quantitative modelling of signaling in aggressive B cell lymphoma unveils conserved core network

Quantitative interplay between activating and pro-apoptotic signals dictates T cell responses

Naive CD4 T Cells Constitutively Express CD40L and Augment Autoreactive B Cell Survival

Combination of High-Resolution Structures for the B Cell Receptor and Co-Receptors Provides an Understanding of Their Interactions with Therapeutic Antibodies

B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: Modulation by BCR and CD40, and relevance to T-independent antibody responses

Dynamic regulation of B cell complement signaling is integral to germinal center responses

Enhanced B Cell Receptor Signaling Partially Compensates for Impaired Toll-like Receptor 4 Responses in LPS-Stimulated IκBNS-Deficient B Cells

Towards a unifying model for B-cell receptor triggering

Modeling the B-cell receptor signaling on single cell level reveals a stable network circuit topology between nonmalignant B cells and chronic lymphocytic leukemia cells and between untreated cells and cells treated with kinase inhibitors

Direct observation correlates NFκB cRel in B cells with activating and terminating their proliferative program

A model for the integration of conflicting exogenous and endogenous signals by dendritic cells

Quantitative modeling of the terminal differentiation of B cells and mechanisms of lymphomagenesis

A TLR9-dependent Checkpoint Governs B Cell Responses to DNA-containing Antigens.